Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,071 | 126,971 | 135,617 | 73,412 | 124,984 |
| Marketable Securities | 13,143 | N/A | 14,493 | 44,980 | 49,900 |
| Receivables | N/A | N/A | N/A | N/A | 26 |
| Other current assets | 2,821 | 3,537 | 21,495 | 34,950 | 33,350 |
| TOTAL | $112,241 | $145,477 | $171,605 | $153,342 | $208,260 |
| Non-Current Assets | |||||
| PPE Net | 11,859 | 12,773 | 13,791 | 14,547 | 14,873 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 799 | 798 | 799 | 799 | 799 |
| TOTAL | $16,221 | $17,134 | $18,153 | $18,909 | $19,235 |
| Total Assets | $128,462 | $162,611 | $189,758 | $172,251 | $227,495 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,365 | 15,714 | 10,144 | 16,140 | 14,669 |
| Accrued Expenses | 9,394 | 9,050 | 18,204 | 18,429 | 24,667 |
| Other current liabilities | 3,865 | 3,631 | 3,082 | 1,378 | 7,291 |
| TOTAL | $27,624 | $28,395 | $31,430 | $35,947 | $47,296 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 669 |
| Other Non-Current Liabilities | 103,931 | 103,683 | 103,425 | 105,513 | 102,559 |
| TOTAL | $103,926 | $103,681 | $103,421 | $105,447 | $103,240 |
| Total Liabilities | $131,550 | $132,076 | $134,851 | $141,394 | $150,536 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,163 | 60,142 | 57,945 | 51,347 | 51,288 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -819,789 | -775,492 | -726,425 | -667,436 | -612,100 |
| Other shareholders' equity | -2,058 | -2,039 | -2,033 | -1,956 | -2,024 |
| TOTAL | $-3,088 | $30,535 | $54,907 | $30,857 | $76,959 |
| Total Liabilities And Equity | $128,462 | $162,611 | $189,758 | $172,251 | $227,495 |